Physician profile
Howard Cohen
NPI 1962516112
$5,534.43
in general payments reported to CMS, 2019-2025
44 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,690 · 2020: $477 · 2021: $859 · 2022: $766 · 2023: $722 · 2024: $375 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,177.65 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Amgen INC. | $504.39 | 2019-2023 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $484.29 | 2019-2024 | Austedo Xr |
| Allergan, INC. | $435.72 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $297.85 | 2019-2025 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $284.60 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $230.43 | 2020-2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $225.34 | 2019 | |
| Lilly USA, LLC | $194.10 | 2019-2023 | Reyvow, Emgality |
| Medtronic, INC. | $169.04 | 2023 | Intellis Adaptivestim |
| Axsome Therapeutics, INC. | $158.29 | 2025 | Auvelity, Symbravo |
| Lundbeck LLC | $138.78 | 2019-2024 | Vyepti |
| Scilex Pharmaceuticals INC. | $114.36 | 2021-2022 | |
| Pfizer INC. | $110.05 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $90.67 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.